Hiroki Ikeda
St. Marianna University School Of Medicine
Kawasaki, Japan
Kawasaki, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Association Between Immune-Related Adverse Events and Survival in Patients with Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab.
Journal: The oncologist
Published: October 25, 2022
Risk factors for liver-related mortality of patients with hepatitis C virus after sustained virologic response to direct-acting antiviral agents.
Journal: JGH open : an open access journal of gastroenterology and hepatology
Published: March 03, 2022
The Impact of Cirrhosis and History of Hepatocellular Carcinoma on All-Cause Mortality After Eradication of Hepatitis C Virus in Patients With Chronic Hepatitis C.
Journal: Gastro hep advances
Published: December 13, 2021
Prediction of esophagogastric varices associated with oxaliplatin administration.
Journal: JGH open : an open access journal of gastroenterology and hepatology
Published: June 25, 2021
Efficient Colonoscopic Identification of Colonic Bleeding Diverticulum Using Intradiverticular Water Injection with a Nontraumatic Tube.
Journal: Journal of the anus, rectum and colon
Published: February 11, 2021
Endoscopic Transpapillary Gallbladder Drainage for Acute Cholecystitis After Biliary Self-Expandable Metal Stent Placement.
Journal: Surgical laparoscopy, endoscopy & percutaneous techniques
Published: May 14, 2020
Pancreatic duct guidewire placement for biliary cannulation as a risk factor for stone residue after endoscopic transpapillary stone removal.
Journal: BMC gastroenterology
Published: March 30, 2020
Marked heterogeneity in the diagnosis of compensated cirrhosis of patients with chronic hepatitis C virus infection in a real-world setting: A large, multicenter study from Japan.
Journal: Journal of gastroenterology and hepatology
Published: October 22, 2019
The effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients with refractory factors in the real world: a comprehensive analysis of a prospective multicenter study.
Journal: Hepatology international
Published: September 18, 2019
Real-world experience of 12-week direct-acting antiviral regimen of glecaprevir and pibrentasvir in patients with chronic hepatitis C virus infection.
Journal: Journal of gastroenterology and hepatology
Published: July 10, 2019
Last Updated: 09/26/2026